Differential sensitivities of the vascular K(ATP) channel to various PPAR activators

Several agonists of the peroxisome proliferator-activated receptors (PPARs) are currently used for the treatment of metabolic disorders including diabetes. We have recently shown that one of them, Rosiglitazone, inhibits the vascular ATP-sensitive K(+) (K(ATP)) channel and compromises the coronary v...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Wang, Yingji, Yu, Lei, Cui, Ningren, Jin, Xin, Zhu, Daling, Jiang, Chun
Формат: Artigo
Язык:Inglês
Опубликовано: 2013
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4132832/
https://ncbi.nlm.nih.gov/pubmed/23500542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2013.02.039
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы